WORLD DISEASES

World Arthritis

Argenx Discontinued Phase 3 Sjögren's Disease Trial

Argenx Discontinued Phase 3 Sjögren's Disease Trial

A clinical trial for the treatment of moderate-to-severe Sjögren's disease has been halted for futility.

Live Poll

Do you trust pharmaceutical companies to prioritize patient health outcomes over successful clinical trial results?


Recent news


More in Arthritis